The Bank of Nova Scotia (BNS) Up 5.4% — Do I Enter the Trade Here?

  • BNS rose 5.37% to $91.52 from $86.86 the previous trading day
  • Weiss Ratings assigns B+ (Buy)
  • Market cap is $106.02B with a dividend yield of 3.66%

The Bank of Nova Scotia (BNS) surged 5.37% on Tuesday, adding $4.66 to close at $91.52 on the NYSE in one of its most decisive single-session moves in recent memory. The advance carries particular weight given where shares now sit relative to the 52-week high of $92.04, reached just eight days ago on August 17, 2026 — putting BNS within a half-percent of retesting that peak and potentially breaking through to fresh territory.

Trading volume came in at approximately 1.63 million shares, running below the 90-day average of roughly 2.41 million. Despite the lighter-than-usual turnover, the price action was emphatically constructive — a clean, sustained advance rather than a volatile spike, suggesting the session's buyers were deliberate and conviction-driven.


Why The Bank of Nova Scotia Price is Moving Higher

The catalyst driving BNS sharply higher is straightforward: Scotiabank delivered a standout Q3 earnings beat that left little room for skepticism. Adjusted diluted EPS came in at C$2.28 against the C$2.08 analyst consensus — a C$0.20, or 9.6%, beat that immediately shifted market sentiment. Revenue climbed 11% year over year to C$10.535 billion from C$9.486 billion, exceeding the C$9.97 billion estimate by approximately C$565 billion. Reported net income rose 17% to C$2.953 billion, while adjusted net income advanced 18% to C$2.973 billion — figures that make a compelling case that the bank's earnings engine is accelerating rather than merely holding steady.

What separates this quarter from a routine beat is the breadth of outperformance across every major business segment. Global Wealth Management posted record earnings of C$518 million, up 23%, with assets under management rising 16% to C$474 billion — a milestone that signals durable fee-generating momentum beyond traditional lending. Global Banking and Markets delivered record earnings of C$647 million, up 37%, powered by a revival in capital-markets activity and underwriting fees. Canadian Banking earnings rose 12% to C$1.071 billion, and International Banking contributed C$766 million, up 8%. Crucially, adjusted ROE improved to 14.2% from 12.4%, pushing above management's own 14% medium-term target — a threshold that now looks less like a ceiling and more like a floor.

Analyst activity reinforced the positive reaction heading into the print. CIBC had already raised its price target on BNS from C$122 to C$136 as recently as August 19, a move that primed institutional investors for upside. With management confirming it has exceeded its medium-term objectives — without issuing a cautious guidance revision — the market had every reason to close the gap between price and fundamental value in a single session. The result is a stock pressing against its 52-week high with the earnings evidence to justify the move.


What is the The Bank of Nova Scotia Rating - Should I Buy?

Weiss Ratings assigns BNS a B+ rating. Current recommendation is Buy. That rating places Scotiabank among the stronger names in the Financials sector, supported by a fundamental profile that held up well before Tuesday's earnings print and looks considerably stronger coming out of it. Revenue growth of 16.96% earns the Excellent Growth Index — a standout rate for a globally diversified bank navigating varied credit environments across Canada, Latin America, and capital markets simultaneously. A 29.07% profit margin reinforces that the bank's revenue expansion is translating into real earnings power rather than simply inflating the top line.

The Excellent Efficiency Index reflects an ROE of 11.07% — a figure that, while modestly below the 14.2% adjusted level Scotiabank reported internally for Q3 2026, still demonstrates that the bank is generating meaningful earnings relative to shareholder equity across the full business cycle. The Excellent Solvency Index is arguably the most important data point for a major financial institution: it signals that Scotiabank's balance sheet carries the capital strength to absorb credit stress without compromising its dividend or strategic flexibility. The Good Total Return Index and Good Volatility Index round out a profile that rewards patient, income-oriented investors while acknowledging that a globally active bank will experience meaningful price swings tied to macro and currency developments.

Within the Financials sector, Scotiabank sits alongside Citigroup Inc. (C, B+) and ranks ahead of JPMorgan Chase & Co. (JPM, B), Bank of America Corporation (BAC, B), and Wells Fargo & Company (WFC, B). Royal Bank of Canada (RY, A-) sits above BNS on the ratings ladder, setting a credible benchmark for where Scotiabank could move if the current earnings trajectory sustains. At a forward P/E of 16.48 — a reasonable multiple for a bank generating record segment earnings and an ROE now exceeding its own medium-term target — the valuation case supports the Buy recommendation without requiring aggressive assumptions about future growth.


About The Bank of Nova Scotia

The Bank of Nova Scotia (BNS) is a Financials company operating and one of Canada's largest financial institutions by assets, with operations spanning retail banking, commercial lending, wealth management, and capital markets across more than 30 countries. The bank's domestic franchise — Canadian Banking — anchors the business with a broad network of branches, mortgage lending, credit cards, and small business services that generate stable, recurring earnings regardless of broader market conditions. That base provides the capital generation capacity to fund the bank's more dynamic international and institutional segments.

Scotiabank's international footprint is a defining competitive differentiator, concentrated in the Pacific Alliance countries of Mexico, Peru, Chile, and Colombia — economies that offer demographic tailwinds and banking penetration rates well below Canadian and U.S. norms. International Banking contributes meaningfully to earnings while positioning the bank to benefit from long-run growth in retail and commercial credit across emerging markets where many global peers have limited reach. This geographic diversification insulates BNS from over-reliance on any single credit cycle or interest rate environment.

Global Wealth Management and Global Banking and Markets complete the picture, transforming Scotiabank from a traditional deposit-and-lending institution into a diversified financial services group capable of capturing fee income from asset management, underwriting, advisory, and trading activity. With C$474 billion in assets under management and record earnings in both its wealth and capital markets divisions as of Q3 2026, the bank has demonstrated it can grow higher-margin, capital-light revenue streams alongside its core lending business — a combination that supports both dividend sustainability and long-term return on equity improvement.


Investor Outlook

The Bank of Nova Scotia (BNS) carries a Weiss Rating of B+ (Buy), and Tuesday's earnings-driven surge to within a fraction of its 52-week high sets up a compelling test of whether the stock can break through to new ground on the back of record divisional earnings and an ROE that has now cleared management's own medium-term target. Investors will want to monitor whether the momentum in Global Wealth Management and Global Banking and Markets can be sustained into Q4 2026, and whether the International Banking segment continues to build on its 8% earnings growth as Latin American macro conditions evolve. See full rankings of all B+-rated Financials stocks inside the Weiss Stock Screener.

--

This Weiss Instant News Alert was compiled by narrative data technology, our proprietary ratings models and analysis by Weiss Ratings with the intent of providing our readers with the fastest research and independent coverage. Weiss Instant News Alerts have been reviewed by a member of our editorial staff before publication. Please send any questions or comments about this story to [email protected]
Top Tech Stocks
See All »
B
NVDA NASDAQ $225.07
B
AAPL NASDAQ $341.07
B
AVGO NASDAQ $352.81
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $107.98
A
Top Financial Stocks
See All »
B
B
JPM NYSE $343.06
B
V NYSE $367.38
Top Health Care Stocks
See All »
B
LLY NYSE $1,183.46
B
JNJ NYSE $271.22
B
ABBV NYSE $264.34
Top Real Estate Stocks
See All »
B
PLD NYSE $133.05
B
EQIX NASDAQ $1,008.08